SAN DIEGO, April 28 (Korea Bizwire) — ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended March 31, 2022. Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com Third Quarter 2022 Highlights All comparisons are to the prior year period Revenue increased by 12% to [...]
SAN DIEGO, April 27 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on Tuesday, May 3, 2022, beginning at approximately 8:45 a.m. (Australian Eastern Standard Time) via video webcast. More information about this event, including access to the live webcast, [...]
SAN DIEGO, April 7 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2022 on Thursday, April 28, 2022, after the New York Stock Exchange closes. Following the release, ResMed management will host a webcast to discuss these results. [...]
SAN DIEGO, March 17 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief executive officer, will participate in a virtual fireside chat at the KeyBanc Capital Markets’ Life Sciences & MedTech Investor Forum on Tuesday, March 22, 2022, beginning at approximately 1:30 p.m. (Eastern Daylight Time) via webcast. More information about [...]
SAN DIEGO, March 14 (Korea Bizwire) — ResMed announced today the results of its 2022 Global Sleep Surveys, in conjunction with National Sleep Awareness Week (March 13-19) and World Sleep Day (March 18). The surveys, conducted in the first quarter of the year,1 asked nearly 25,000 respondents in 12 countries what’s keeping them up at night [...]
SAN DIEGO, March 10 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced Rob Douglas, president and chief operating officer, will present at the Oppenheimer 32nd Annual Healthcare Conference on Tuesday, March 15, 2022, beginning at approximately 1:20 p.m. (Eastern Daylight Time) via webcast. More information about this event, including access to the live webcast, [...]
SAN DIEGO, Feb. 1 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced the appointment of Urvashi Tyagi as chief technology officer (CTO), effective today. As CTO, Tyagi will lead ResMed’s Digital Health Technology team, driving the innovation and adoption of its world-leading cloud-based digital health platforms, as well as investments in emerging technologies [...]
LYON, France, Sept. 8 (Korea Bizwire) — Using PAP (positive airway pressure) therapy as directed can significantly increase sleep apnea patients’ chances of living longer, according to a late-breaking abstract presented today at the virtual European Respiratory Society (ERS) International Congress 2021 and supported by ResMed (NYSE: RMD, ASX: RMD). The landmark ALASKA study, “CPAP [...]
SAN DIEGO, Aug. 25 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD), today announced the promotion of Bobby Ghoshal to President of ResMed’s SaaS business, effective immediately. Raj Sodhi will be leaving full-time employment at ResMed, effective September 1. Bobby has over 25 years of experience across medical and technology industries, most currently serving as [...]
SAN DIEGO, Aug. 16 (Korea Bizwire) — ResMed, a global leader in digital health and sleep apnea treatment, (NYSE: RMD, ASX: RMD) today launched AirSense 11, available first in the U.S., the company’s next-generation PAP (positive airway pressure) device designed to help hundreds of millions of people worldwide with sleep apnea1 start and stay on therapy [...]